Topical Peptides for Hair Growth

Topical peptides are studied for hair growth because certain peptides — copper peptides such as GHK-Cu most prominently — signal the hair follicle to prolong the anagen (growth) phase and inhibit 5-alpha-reductase, the enzyme central to pattern hair loss, though the human scalp evidence is thinner and earlier-stage than the skin-wrinkle data.

This guide covers how topical peptides act on follicles, the GHK-Cu hair evidence, scalp-delivery considerations, and how topical serums compare to ingestible options. For the molecule itself, see the GHK-Cu topical peptide guide.

How do topical peptides work for hair growth?

The hair follicle cycles through anagen (growth), catagen (regression), and telogen (rest). Pattern hair loss shortens anagen under the influence of dihydrotestosterone (DHT), produced from testosterone by 5-alpha-reductase. Topical peptides studied for hair act on these levers:

• Copper peptides (GHK-Cu) — copper inhibits 5-alpha-reductase, and copper-peptide complexes have prolonged anagen and enlarged follicles in animal and follicle-culture models.
• GHK-Cu signalling — the same collagen, VEGF, and angiogenesis pathways that aid skin repair support the perifollicular environment.

What does research show about topical copper peptides for hair?

Copper-peptide complexes have stimulated hair follicle growth and prolonged anagen in animal and ex-vivo models, and GHK-Cu specifically upregulates VEGF-driven angiogenesis that supports follicular blood supply (Pickart & Margolina, 2018, PMID: 29987172). The controlled human scalp evidence is more limited than the skin-aging literature, so claims should be framed cautiously and as research, not as a proven hair-loss treatment. The 500-Dalton absorption rule applies to scalp delivery as it does to facial skin (Bos & Meinardi, 2000, PMID: 11168751), and follicular penetration via the hair-shaft route is an active formulation question.

Topical serum vs ingestible peptides for hair density

A topical serum places the peptide directly at the scalp and follicle, whereas ingestible "peptide" supplements (often hydrolysed collagen) act systemically and are not the same molecules as signalling peptides like GHK-Cu. For follicle-targeted signalling, topical delivery is the more direct route; the trade-off is the absorption limit of the stratum corneum. We compare local versus systemic delivery in topical vs injectable peptides.

How to evaluate a topical peptide hair serum

Check the molecular weight (GHK-Cu's 340 Da favours absorption), the copper-peptide concentration, the delivery vehicle (penetration enhancers and follicular-targeting systems improve uptake), and the verification data — purity by HPLC and a batch certificate of analysis. Many scalp products combine copper peptides with established hair actives; the peptide component is best evaluated on its own evidence.

Why does molecular weight matter for scalp delivery?

The scalp presents the same barrier as facial skin — a stratum corneum that excludes most molecules above ~500 Da (Bos & Meinardi, 2000, PMID: 11168751) — so a peptide intended to reach the follicle must either be small enough to cross or be carried by a penetration-enhancing system. GHK-Cu's 340 Da size is favourable on this measure, which is part of why it features in copper-peptide hair research. An additional route specific to the scalp is follicular penetration along the hair shaft and through the follicular opening, which can bypass some of the stratum-corneum limitation; optimising this route is an active formulation question. The practical implication is that a hair serum's stated peptide is only as useful as the fraction that actually reaches the follicle.

Do topical peptides work for hair loss or only thinning?

Topical copper peptides are studied as a follicular-signalling input rather than as a proven treatment for established pattern hair loss, and the strongest mechanistic rationale is for supporting the growth phase and follicular environment rather than reversing advanced loss. Copper inhibits 5-alpha-reductase and GHK-Cu supports perifollicular angiogenesis, but the controlled human scalp evidence remains earlier-stage than the skin-aging data. Claims should therefore be framed as research, and anyone evaluating peptides for clinical hair loss should consult a qualified clinician.

Aevitas GHK-Cu — Research Grade

For follicular and copper-peptide hair research, GHK-Cu is the reference material. Aevitas supplies GHK-Cu at ≥98% HPLC purity with a third-party COA in every batch.

[Read the GHK-Cu monograph →](/peptides/ghk-cu) · [Order GHK-Cu (50 mg) →](/product/ghk-cu-50mg) · View COA Library →

Frequently Asked Questions

Do topical peptides work for hair growth? Copper peptides such as GHK-Cu have prolonged the anagen growth phase and stimulated follicles in animal and ex-vivo models, but controlled human scalp evidence is more limited than the skin data, so they remain a research subject rather than a proven treatment.

How do copper peptides help hair? Copper inhibits 5-alpha-reductase (the enzyme that drives DHT-related hair loss), and GHK-Cu upregulates VEGF-driven angiogenesis that supports the follicle's blood supply.

Is a topical serum or ingestible peptide better for hair density? A topical serum delivers signalling peptides directly to the scalp, while most ingestible "peptide" supplements are hydrolysed collagen acting systemically — a different category from follicle-signalling peptides.

Do topical peptides for hair have side effects? Reported effects are generally mild application-site irritation; the materials discussed are Research Use Only and this is not medical advice.

What molecular weight matters for scalp absorption? The stratum corneum excludes most molecules above ~500 Da, so GHK-Cu's 340 Da is favourable for penetration relative to larger peptides.

---

Research Use Only · Not for human consumption · Not for veterinary use · None of the information on this page constitutes medical advice.

Related: GHK-Cu topical guide · Topical peptides pillar · Best topical peptides